During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Ali Bazarbachi, American University of Beirut Medical Center, Beirut, LB, about allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with AML.